Isoniazid 내성 폐결핵의 치료실태와 치료성적 = Treatment of Isoniazid-Resistant Pulmonary Tuberculosis

참고문헌 (Reference)

1 "한국인 결핵환자에서 Isoniazid와 Rifampicin의 약동학" 47 : 442-450, 1999

2 "한 민간종합병원에서 진단된 폐결핵 환자의 특성과 치료성적" 55 : 154-64, 2003

3 "한 민간종합병원에서 진단된 폐결핵 환자의 약제내성 실태조사. 결핵 및 호흡기질환" 55 (55): 83-, 2003

4 "폐결핵 진료의 기준,1997" 44 : 1447-1453, 1997

5 "우리나라 결핵균 검사의 현재와 미래 임상의의 기대" 17 : S26-s31, 1997

6 "우리나라 결핵균 검사의 현재와 미래 어디까지 해야하나" 17 : S20-s25, 1997

7 "우리 나라 결핵어제, 오늘, 내일. 결핵 및 호흡기질환" 44 : 1-10, 1997

8 "국내 결핵균 검사 기관의 결핵균 검사 실태의 변화" 4 : 108-114, 2001

9 "국내 3차 및 대학병원에서의 결핵균 검사 실태조사" 19 : 86-91, 1999

10 "Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy" 120 : 1520-1524, 2001

11 "Treatment of tuberculosis: guidelines for national programmes" World Health Organization 2003

12 "Treatment of tuberculosis and tuberculosis infection in adults and children" 149 : 1359-1374, 1994

13 "Treatment of isoniazid-resistant tuberculosis with isoniazid and pyrazinamide for 6 months" 6 : 952-958, 2002

14 "Treatment of isoniazid-resistant tuberculosis in southeastern Texas" 119 : 1730-1736, 2001

15 "The treatment of tuberculosis in South Korea" 7 : 912-919, 2003

16 "The resurgence of tuberculosis: is your laboratory ready?" 31 : 767-770, 1993

17 "Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications" 3 (3): S231-S279, 1999

18 "Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries" 283 : 2537-2545, 2000

19 "Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance" 262-4, amrevrespirdis1981

20 "Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloꠀxacin-containing regimens" 117 : 744-751, 2000

21 "Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin" 2 : 877-884, 1998

22 "Multidrug-resistant tuberculosis in patients without HIV infection" 333 : 907-911, 1995

23 "Low serum antimycobacterial drug levels in non-HIV- infected tuberculosis patients" 113 : 1178-1183, 1998

24 "International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control" 5 : 213-215, 2001

25 "Influence of initial drug resistance on the response to short- course chemotherapy of pulmonary tuberꠀculosis" 133 : 423-30, 1986

26 "Guidelines for the management of drug-resistant tuberculosis" World Health Organization 1997

27 "Global trends in resistance to antituberculosis drugs. World Health Organization-International Uniꠀon against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance" 344 : 1294-1303, 2001

28 "Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis" 136 : 1339-42, 1987

29 "Drug-resistant tuberculosis in Korea,1994" 1 : 302-308, 1997

30 "Diagnostic standards and classification of tuberculosis in adults and children" 161 : 1376-1395, 2000

31 "Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberꠀculosis" 1 : 171-4, 1981

32 "Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant tuberculosis" 69 : 5-14, 1988

33 "Clinical trial of six- month and four-month regimens of chemoꠀ therapy in the treatment of pulmonary tuberꠀ" 579-85, amrevrespirdis1979

34 "Chemotherapy and management of tuberculosis in the United Kingdom:recommendations 1998" 53 : 536-548, 1998

35 "Chapter 48. Management of multidrug-resistant tuberculosis. In:Tuberculosis" Lippincott Williams & Wilkins 729-738, 2004

36 "Can a nine-month regimen be used to treat isoniꠀ azid resistant tuberculosis diagnosed after standard treatment is started" 42 : 1-3, 2001

37 "American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis" 167 : 603-662, 2003

38 "2002년 결핵관리지침" 국립보건원 2002